Whether patients with clinical stage I nonseminomatous testicular germ-cell cancer (NSGCT) should be treated with orchiectomy and retroperitoneal lymph node dissection (RPLND) or orchiectomy and surveillance remains
Axel Heidenreich, MD
Advertisement
Articles by Axel Heidenreich, MD
Advertisement
Latest Updated Articles
- Prognostic Factors in Low-Stage Nonseminomatous Testicular Cancer
Published: August 31st 1996 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer
3
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
4
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
5
